Viewing data from:

ALOPRIM

NDA

ALLOPURINOL SODIUM | N020298 | MYLAN INSTITUTIONAL LLC A VIATRIS CO

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

1 trial from ClinicalTrials.gov — 1 recruiting

Trial	Phase	Status	Sponsor	Enrollment	Dates
Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm NCT04026776	Early Phase 1	Recruiting	Wake Forest University Health Sciences	120	2020-09-02 → 2026-12

Source: ClinicalTrials.gov. Trials matched by ingredient name.

Approval Letters

3 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 500MG BASE/VIAL

RLDAP

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: May 17, 1996

No patent or exclusivity listings for this strength.